1. Bray F, Ferlay J, Soerjomataram I, et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. PMID: 30207593 DOI: 10.3322/caac.21492.
2. Yang Y, Huang X, Sun J, et al (2015) Prognostic value of perineural invasion in colorectal cancer: A meta- analysis. J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract 19:1113–1122. PMID: 25663635 DOI: 10.1007/s11605-015-2761-z.
3. Benson AB, Venook AP, Al-Hawary MM, et al (2018) Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 16(7), 874–901 PMID: 30006429. DOI:10.6004/jnccn.2018.00
4. Ryan JE, Warrier SK, Lynch AC, et al (2015) Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A systematic review. Colorectal Dis. Off. J. Assoc. Coloproctol. Great Br. Irel 17: 849–861. PMID:26260213 DOI: 10.1111/codi.13081.
5. Martin ST, Heneghan HM, Winter DC (2012) Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 99: 918–28. PMID: 22362002 DOI: 10.1002/bjs.8702
6. de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al (2011) Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol 18:1590-8, PMID:21207164 DOI: 10.1245/s10434-010-1506-1
7. Sauer R, Liersch T, Merkel S, et al (2012) Preoperative versus postoperative chemora-diotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30: 1926–33. PMID:22529255 DOI: 10.1200/jco.2011.40.1836
8. Bosset JF, Collette L, Calais G, et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med 355:1114–1123. PMID: 16971718 DOI: 10.1056/NEJMoa060829
9. Silberfein EJ, Kattepogu KM, Hu CY, et al (2010) Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol 17:2863-9 PMID: 20552409 DOI: 10.1245/s10434-010-1119-8
10. Couwenberg AM, Burbach JPM, van Grevenstein WMU, et al (2018) Effect of Neoadjuvant Therapy and Rectal Surgery on Health-related Quality of Life in Patients With Rectal Cancer During the First 2 Years After Diagnosis. Clin Colorectal Cancer 17:e499–e512 PMID: 29678514 DOI: 10.1016/j.clcc.2018.03.009
11. Ashburn JH, Kalady MF (2016) Radiation-Induced Problems in Colorectal Surgery. Clin Colon Rectal Surg 29:85–91. PMID: 27247532 DOI: 10.1055/s-0036-1580632
12. Delphine Dayde, Ichidai Tanaka, Jain R, et al (2017) Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer J Mol Sci Mar 7;18(3):573 PMID: 28272347 DOI: 10.3390/ijms18030573
13. Weiser MR (2018) AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol 25(6):1454-1455. PMID: 29616422 DOI: 10.1245/s10434-018-6462-1
14. Nougaret S, Reinhold C, Mikhael HW, et al (2013) The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? Radiology 268: 330–44. PMID: 23882096 DOI: 10.1148/radiol.13121361
15. Prampolini F, Taschini S, Pecchi A, et al (2020) Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion. Abdom Radiol (NY) 45(10):2941-2949. PMID: 30483843 DOI: 10.1007/s00261-018-1838-z
16. Mage AG, Pai RK, Stocchi L, et al (2015) American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer. Dis Colon Rectum 58(1):32-44.PMID: 25489692 DOI: 10.1097/DCR.0000000000000266
17. García-aguilar J, Hernandez de Anda E, Sirivongs P, et al (2003) A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treat- ed by mesorectal excision. Dis Colon Rectum 46:298–304. PMID: 12626903 DOI: 10.1007/s10350-004-6545-x
18. Yoon SM, Kim DY, Kim TH, et al (2007) Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 69:1167-72. PMID: 17967307 DOI: 10.1016/j.ijrobp.2007.04.047
19. Varlotto J, Stevenson MA (2005) Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 63:25–36. PMID: 16111569 DOI: 10.1016/j.ijrobp.2005.04.049
20. Das P, Skibber JM, Rodriguez-Bigas MA, et al (2007) Predictors of tumor response and downstaging in patients who receive preop- erative chemoradiation for rectal cancer. Cancer 109: 1750–1755. PMID: 17387743 DOI: 10.1002/cncr.22625.
21. Sun Y, Wu X, Lin H, et al (2021) Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model Journal of Gastrointestinal Surgery. 25(4):1019-1028. PMID: 32219686 DOI: 10.1007/s11605-020-04566-x
22. Shivakumar L, Ansell S (2006) Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferationinducing ligand in hematologic malignancies. Clin Lymphoma Myeloma 7: 106-108 PMID: 17026820 DOI: 10.3816/CLM.2006.n.046.
23. ChenY, Chen K, Xiao X, et al (2016) Pretreatment Neutrophil-To-Lymphocyte Ratio Is Correlated With Response to Neoadjuvant Chemotherapy as an Independent Prognostic Indicator in Breast Cancer Patients: A Retrospective Study. BMC Cancer 19; 16:320. PMID:27198767 DOI: 10.1186/s12885-016-2352-8
24. Huh JW, Lee JH, Kim HR, et al (2013) Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. The American Journal of Surgery 206(5), 758-763. PMID:23835209 DOI: 10.1016/j.amjsurg.2013.02.010
25. Yuchong Yang, Xuanzhang Huang, Jingxu Sun, et al (2015) Prognostic Value of Perineural Invasion in Colorectal Cancer: A Meta-Analysis J Gastrointest Surg 19(6):1113- 22 PMID:25663635 DOI 10.1007/s11605-015-2761-z
26. Nikberg M, Chabok A, Letocha H, et al (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncologica 55(12), 1418–1424. PMID: 27732105 DOI:10.1080/0284186x.2016.1230274
27. Tripathi, P, Rao SX, Zeng, MS (2017) Clinical value of MRI-detected extramural venous invasion in rectal cancer. Journal of Digestive Diseases 18(1), 2–12. PMID: 28009094 DOI: 10.1111/1751-2980.12439
28. Smith NJ, Barbachano Y, Norman AR, et al (2018) Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 95:229-36 PMID: 17932879 DOI: 10.1002/bjs.5917
29. Sohn B, Lim JS, Kim H, et al (2015) MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 25:1347-55. PMID: 25500963 DOI: 10.1007/s00330-014-3527-9